2011～2015年上海市闵行区第二类疫苗使用情况分析
|
摘要
目的分析上海市闵行区2011~2015年第二类疫苗的使用情况,为加强第二类疫苗的接种管理提供依据。方法从中国免疫规划信息系统和上海市闵行区生物制品管理信息系统中导出上海市闵行区2011~2015年第二类疫苗使用情况数据,并进行整理和描述性分析。结果 2011~2015年,上海市闵行区使用的第二类疫苗的种类基本稳定,使用量及占疫苗总使用量的比例逐年上升,分别由51.60万剂/年上升至57.82万剂/年、36.67%上升至42.48%;非本市户籍人口的第二类疫苗使用量高于本市户籍人口;可替代第一类疫苗的第二类疫苗使用总量逐年递增,总替代比例从17.92%增至36.68%,其中以A+C群流脑结合疫苗替代A群流脑多糖疫苗比例最高。结论2011~2015年上海市闵行区第二类疫苗使用品种多、使用数量大,有效地预防和控制了疫苗可预防疾病的发生。
Objective To analyze the application of vaccines of class Ⅱ in Minhang District, Shanghai City, China during2011 ~ 2015, and to provide a basis for strengthening the vaccination service management of the vaccines. Methods Data on application of vaccines of class Ⅱ in Minhang District from 2011 to 2015 were derived from the China Immunization Information System and the Biological Product Management Information System for descriptive analysis.Results In 2011 ~ 2015, the kinds of vaccines of class Ⅱ used in Minhang District remained stable. However, the amounts used and the proportion in total vaccines used increased from 516 000 to 578 200 doses and from 36. 67% to42. 48% respectively. The amount used of vaccines of class Ⅱ in floating population was higher than that in local population. The amount used of vaccines of class Ⅱ as substitutes of those of class Ⅰ increased year by year, while the substitution rate increased from 17. 92% to 36. 68%. However, the substitution rate of groups A + C to group A meningococcal conjugate vaccine was the highest. Conclusion Varieties of vaccines of class Ⅱ were used in a large quantity in Minhang District during 2011 ~ 2015, which prevented and controlled the vaccine preventable diseases effectively.
Objective To analyze the application of vaccines of class Ⅱ in Minhang District, Shanghai City, China during2011 ~ 2015, and to provide a basis for strengthening the vaccination service management of the vaccines. Methods Data on application of vaccines of class Ⅱ in Minhang District from 2011 to 2015 were derived from the China Immunization Information System and the Biological Product Management Information System for descriptive analysis.Results In 2011 ~ 2015, the kinds of vaccines of class Ⅱ used in Minhang District remained stable. However, the amounts used and the proportion in total vaccines used increased from 516 000 to 578 200 doses and from 36. 67% to42. 48% respectively. The amount used of vaccines of class Ⅱ in floating population was higher than that in local population. The amount used of vaccines of class Ⅱ as substitutes of those of class Ⅰ increased year by year, while the substitution rate increased from 17. 92% to 36. 68%. However, the substitution rate of groups A + C to group A meningococcal conjugate vaccine was the highest. Conclusion Varieties of vaccines of class Ⅱ were used in a large quantity in Minhang District during 2011 ~ 2015, which prevented and controlled the vaccine preventable diseases effectively.
引文
[1]中华人民共和国国务院.国务院关于修改《疫苗流通和预防接种管理条例》的决定[Z/OL].(2016-04-23)[2017-07-27].http://www.gov.cn/zhengce/content/2016-04/25/content_5067597.htm.中华人民共和国国务院令第668号.
[2]上海市闵行区统计局.闵行区统计信息网[EB/OL].(2016-10-22)[2017-07-27].http://tj.shmh.gov.cn.2011-2015.
[3]李娟,杨雨生.《疫苗流通和预防接种管理条例》之管窥[J].微生物学免疫学进展,2005,33(3):97-98.
[4]YAN W,ZHAI L J,ZHOU Y L.Survey on the immunization knowledge of category B vaccine in Dongcheng district,Beijing[J].Cap J Pub Health,2014,8(4):165-167.(in Chinese)闫威,翟力军,周艳丽.北京市东城区第二类疫苗免疫接种知识调查[J].首都公共卫生,2014,8(4):165-167.
[5]WANG Z B,WANG W,GUO W S,et al.Survey on vaccination rate of second class vaccine and influencial factors in children in rural areas of nine counties in Hennan province[J].Prog in Microbiol Immunol,2013,41(3):53-61.(in Chinese)王志彬,王伟,郭万申,等.河南省9个县农村地区儿童第二类疫苗接种率及影响因素调查[J].微生物学免疫学进展,2013,41(3):53-61.
[6]YE L X,FANG T,MA R,et al.Application of the second type vaccines in Ningbo,2008-2011[J].Chin Rural Health Serv Administ,2013,33(9):1026-1029.(in Chinese)叶莉霞,方挺,马瑞,等.2008-2011年宁波市第二类疫苗使用情况调查分析[J].中国农村卫生事业管理,2013,33(9):1026-1029.
[7]FANG Q,WANG Y G,CAO L,et al.Analysis on reported data of the second type vaccine in Fugang district of Shenzhen city,2009-2013[J].Chin J Dis Control Prev,2016,20(5):536-538.(in Chinese)方琼,王永刚,曹丽,等.2009-2013年深圳市福田区第二类疫苗使用情况监测分析[J].中华疾病控制杂志,2016,20(5):536-538.
[8]上海市卫生和计划生育委员会.2016年度上海市第二类疫苗接种建议[EB/OL].(2016-09-09)[2017-07-27].http://www.wsjsw.gov.cn/wsj/n429/n432/n1487/n1507/u1ai138460.html.
[9]WANG Z Z.Study on inoculation state about the second type vaccines in Fengtai district of Beijing[J].Mod Prev Med,2010,37(9):1662-1663,1666.(in Chinese)王中战.北京市丰台区第二类疫苗接种情况分析[J].现代预防医学,2010,37(9):1662-1663,1666.
[10]倪进东,叶冬青.对第二类疫苗接种服务中存在问题的分析[J].中国公共卫生管理,2009,25(5):484-485.
[11]PRINJA S,GUPTA M,SINGH A,et al.Effectiveness of planning and management interventions for improving age-appropriate immunization in rural India[J].Bull WHO,2010,88(2):97.
[12]TIAN L J,LIN L,LIU X X.The analysis and enlightenment on the series cases of illegal supply of vaccine in Ji'nan of Shandong[J].J Shenyang Pharm Univ,2017,34(2):176-180,192.(in Chinese)田丽娟,林琳,刘晓溪.山东济南非法经营疫苗系列案件解析及启示[J].沈阳药科大学学报,2017,34(2):176-180,192.
[13]LIU J L,SHI Y H.Reflections on management status quo of charge vaccine[J].J Occup Health Damage,2014,29(6):463-465.(in Chinese)刘继莲,施永辉.第二类疫苗管理现状的思考[J].职业卫生与病伤,2014,29(6):463-465.
[2]上海市闵行区统计局.闵行区统计信息网[EB/OL].(2016-10-22)[2017-07-27].http://tj.shmh.gov.cn.2011-2015.
[3]李娟,杨雨生.《疫苗流通和预防接种管理条例》之管窥[J].微生物学免疫学进展,2005,33(3):97-98.
[4]YAN W,ZHAI L J,ZHOU Y L.Survey on the immunization knowledge of category B vaccine in Dongcheng district,Beijing[J].Cap J Pub Health,2014,8(4):165-167.(in Chinese)闫威,翟力军,周艳丽.北京市东城区第二类疫苗免疫接种知识调查[J].首都公共卫生,2014,8(4):165-167.
[5]WANG Z B,WANG W,GUO W S,et al.Survey on vaccination rate of second class vaccine and influencial factors in children in rural areas of nine counties in Hennan province[J].Prog in Microbiol Immunol,2013,41(3):53-61.(in Chinese)王志彬,王伟,郭万申,等.河南省9个县农村地区儿童第二类疫苗接种率及影响因素调查[J].微生物学免疫学进展,2013,41(3):53-61.
[6]YE L X,FANG T,MA R,et al.Application of the second type vaccines in Ningbo,2008-2011[J].Chin Rural Health Serv Administ,2013,33(9):1026-1029.(in Chinese)叶莉霞,方挺,马瑞,等.2008-2011年宁波市第二类疫苗使用情况调查分析[J].中国农村卫生事业管理,2013,33(9):1026-1029.
[7]FANG Q,WANG Y G,CAO L,et al.Analysis on reported data of the second type vaccine in Fugang district of Shenzhen city,2009-2013[J].Chin J Dis Control Prev,2016,20(5):536-538.(in Chinese)方琼,王永刚,曹丽,等.2009-2013年深圳市福田区第二类疫苗使用情况监测分析[J].中华疾病控制杂志,2016,20(5):536-538.
[8]上海市卫生和计划生育委员会.2016年度上海市第二类疫苗接种建议[EB/OL].(2016-09-09)[2017-07-27].http://www.wsjsw.gov.cn/wsj/n429/n432/n1487/n1507/u1ai138460.html.
[9]WANG Z Z.Study on inoculation state about the second type vaccines in Fengtai district of Beijing[J].Mod Prev Med,2010,37(9):1662-1663,1666.(in Chinese)王中战.北京市丰台区第二类疫苗接种情况分析[J].现代预防医学,2010,37(9):1662-1663,1666.
[10]倪进东,叶冬青.对第二类疫苗接种服务中存在问题的分析[J].中国公共卫生管理,2009,25(5):484-485.
[11]PRINJA S,GUPTA M,SINGH A,et al.Effectiveness of planning and management interventions for improving age-appropriate immunization in rural India[J].Bull WHO,2010,88(2):97.
[12]TIAN L J,LIN L,LIU X X.The analysis and enlightenment on the series cases of illegal supply of vaccine in Ji'nan of Shandong[J].J Shenyang Pharm Univ,2017,34(2):176-180,192.(in Chinese)田丽娟,林琳,刘晓溪.山东济南非法经营疫苗系列案件解析及启示[J].沈阳药科大学学报,2017,34(2):176-180,192.
[13]LIU J L,SHI Y H.Reflections on management status quo of charge vaccine[J].J Occup Health Damage,2014,29(6):463-465.(in Chinese)刘继莲,施永辉.第二类疫苗管理现状的思考[J].职业卫生与病伤,2014,29(6):463-465.